Page 3 - Sarah Gheuens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarah gheuens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarah Gheuens Today - Breaking & Trending Today

Agios Pharma (AGIO) Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946

Agios Pharma (AGIO) Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Sarah Gheuens , Agios Pharmaceuticals Inc , American Society Of Hematology , International Prognostic Scoring System , Agios Pharmaceuticals , Design The , Revised International Prognostic Scoring System , American Society , Annual Meeting ,

Viridian Appoints Sarah Gheuens, M.D., Ph.D., to its Board of Directors

WALTHAM, Mass., September 25, 2023 Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of Sarah Gheuens, M.D., Ph.D., to its Board of Directors. Dr. Gheuens is the Chief Medical Officer (CMO) and Head of R&D of Agios Pharmaceuticals, Inc. ....

United States , Bruxelles Capitale , Sarah Gheuens , Matt Fearer , Tomas Kiselak , Boston Beth Israel Deaconess Medical Center , University Of Antwerp , Corporate Communications , Agios Pharmaceuticals Inc , Free University Of Brussels , Master In Medical Sciences , Viridian Therapeutics Inc , Harvard Medical School , Chief Medical Officer , Agios Pharmaceuticals , Viridian Therapeutics , Viridian Therapeutics Board , Beth Israel Deaconess Medical Center , Free University , University Hospital , Medical Sciences , Harvard Medical , Rare Diseases , Iopharmaceutical Company , Thyroid Eye Disease , Therapeutic Areas ,